With novel payload categories such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, and splice modulators entering the clinic, don't miss this opportunity to meet with ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
कुछ परिणाम छुपे हुए हैं क्योंकि हो सकता है वे आपके लिए पहुँच योग्य न हों.
पहुँच से बाहर के परिणामों को दिखाएँ
प्रतिक्रिया